Prasanth Ganesan

1.9k total citations
144 papers, 1.1k citations indexed

About

Prasanth Ganesan is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Prasanth Ganesan has authored 144 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 32 papers in Pathology and Forensic Medicine and 31 papers in Hematology. Recurrent topics in Prasanth Ganesan's work include Lymphoma Diagnosis and Treatment (25 papers), Acute Lymphoblastic Leukemia research (19 papers) and Chronic Lymphocytic Leukemia Research (16 papers). Prasanth Ganesan is often cited by papers focused on Lymphoma Diagnosis and Treatment (25 papers), Acute Lymphoblastic Leukemia research (19 papers) and Chronic Lymphocytic Leukemia Research (16 papers). Prasanth Ganesan collaborates with scholars based in India, United States and Netherlands. Prasanth Ganesan's co-authors include Tenali Gnana Sagar, Venkatraman Radhakrishnan, Rejiv Rajendranath, Trivadi S. Ganesan, Biswajit Dubashi, Sanju Cyriac, Manikandan Dhanushkodi, Rajaraman Swaminathan, Lalit Kumar and Mukund Seshadri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Prasanth Ganesan

122 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prasanth Ganesan India 18 352 265 207 197 189 144 1.1k
Hikmat Abdel‐Razeq Jordan 17 481 1.4× 132 0.5× 134 0.6× 140 0.7× 195 1.0× 155 1.2k
Sang Kyun Sohn South Korea 20 360 1.0× 309 1.2× 168 0.8× 240 1.2× 218 1.2× 61 1.2k
Charles F. LeMaistre United States 19 525 1.5× 593 2.2× 355 1.7× 199 1.0× 95 0.5× 48 1.2k
Silvia Dehler Switzerland 19 472 1.3× 136 0.5× 111 0.5× 200 1.0× 107 0.6× 43 1.4k
Ranjan Pathak United States 20 408 1.2× 233 0.9× 112 0.5× 157 0.8× 317 1.7× 107 1.5k
Arianna Simonetti Italy 9 342 1.0× 310 1.2× 167 0.8× 361 1.8× 94 0.5× 16 1.1k
Matthew D. Seftel Canada 24 524 1.5× 741 2.8× 401 1.9× 326 1.7× 127 0.7× 111 1.6k
Asim Belgaumi Saudi Arabia 18 305 0.9× 151 0.6× 293 1.4× 301 1.5× 63 0.3× 63 959
Barry Meisenberg United States 21 837 2.4× 640 2.4× 230 1.1× 149 0.8× 179 0.9× 68 1.9k
Atul Sharma India 21 568 1.6× 486 1.8× 161 0.8× 276 1.4× 236 1.2× 176 1.7k

Countries citing papers authored by Prasanth Ganesan

Since Specialization
Citations

This map shows the geographic impact of Prasanth Ganesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasanth Ganesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasanth Ganesan more than expected).

Fields of papers citing papers by Prasanth Ganesan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasanth Ganesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasanth Ganesan. The network helps show where Prasanth Ganesan may publish in the future.

Co-authorship network of co-authors of Prasanth Ganesan

This figure shows the co-authorship network connecting the top 25 collaborators of Prasanth Ganesan. A scholar is included among the top collaborators of Prasanth Ganesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prasanth Ganesan. Prasanth Ganesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganesan, Prasanth, et al.. (2025). Bilateral Exudative Chorioretinopathy in All-trans Retinoic Acid–Associated Differentiation Syndrome. Ophthalmic surgery, lasers & imaging retina. 57(1). 56–59.
2.
3.
4.
Dubashi, Biswajit, Zachariah Bobby, Jaya Prakash Sahoo, et al.. (2023). Cytotoxic chemotherapy is associated with decreased bone mineral density in postmenopausal women with early and locally advanced breast cancer. Archives of Osteoporosis. 18(1). 41–41. 9 indexed citations
5.
6.
Ganesan, Prasanth, et al.. (2023). Central nervous system involvement in multiple myeloma: Experience from a tertiary cancer center and review of literature. Indian Journal of Cancer. 62(3). 416–422. 1 indexed citations
7.
Charles, Lorna, Vikram Kate, Sandhiya Selvarajan, et al.. (2023). Clinicopathological features and survival outcomes for gastric adenocarcinoma: Real-world single-center data. Indian Journal of Gastroenterology. 43(6). 1209–1219.
8.
Sengar, Manju, Adam Fundytus, Wilma M. Hopman, et al.. (2022). Cancer Medicines: What Is Essential and Affordable in India?. JCO Global Oncology. 8(8). e2200060–e2200060. 11 indexed citations
9.
Thejeswar, N, et al.. (2022). Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer. Medical Oncology. 39(12). 233–233. 4 indexed citations
10.
Mehra, Nikita, Manikandan Dhanushkodi, Venkatraman Radhakrishnan, et al.. (2020). A modified olanzapine-based anti-emetic regimen for the control of nausea and vomiting in patients receiving weekly cisplatin. International Journal of Clinical Pharmacy. 42(2). 662–666. 3 indexed citations
11.
Panda, Soumya Surath, Venkatraman Radhakrishnan, Prasanth Ganesan, et al.. (2019). Flow Cytometry Based MRD and Its Impact on Survival Outcome in Children and Young Adults with ALL: A Prospective Study from a Tertiary Cancer Centre in Southern India. Indian Journal of Hematology and Blood Transfusion. 36(2). 300–308. 4 indexed citations
12.
Mehra, Nikita, Prasanth Ganesan, Venkatraman Radhakrishnan, et al.. (2018). Patterns of Infection and Mortality Associated with Intensive AML Induction Therapy: 10 Year Experience from a Tertiary Cancer Centre in India. Blood. 132(Supplement 1). 4008–4008. 4 indexed citations
13.
Ganesan, Prasanth, Venkatraman Radhakrishnan, Trivadi S. Ganesan, et al.. (2018). Prospective evaluation of the toxicity profile, and predictors of toxicity of high dose methotrexate in patients of acute lymphoblastic leukemia/lymphoma. Pediatric Hematology Oncology Journal. 3(1). 1–5. 3 indexed citations
14.
Ganesan, Prasanth, Trivadi S. Ganesan, Venkatraman Radhakrishnan, et al.. (2018). Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era. Indian Journal of Hematology and Blood Transfusion. 35(1). 37–42. 7 indexed citations
15.
Totadri, Sidharth, et al.. (2017). Dietary perceptions and beliefs among families with children undergoing therapy for cancer. SHILAP Revista de lepidopterología. 2(2). 25–28. 6 indexed citations
16.
Ganesan, Prasanth, et al.. (2015). The Effects of Bi-Direction of Work Family Enrichment on Work and Family Related Outcomes among Women Faculty Members. Contemporary Management Research. 9(2). 39. 7 indexed citations
17.
Ganesan, Prasanth, Stacy L. Moulder, J. Jack Lee, et al.. (2014). Triple-Negative Breast Cancer Patients Treated at MD Anderson Cancer Center in Phase I Trials: Improved Outcomes with Combination Chemotherapy and Targeted Agents. Molecular Cancer Therapeutics. 13(12). 3175–3184. 29 indexed citations
18.
Radhakrishnan, Venkatraman, et al.. (2014). Bloodstream infections in pediatric patients at cancer institute, Chennai. Indian Journal of Cancer. 51(4). 418–418. 16 indexed citations
19.
Ganesan, Prasanth, Filip Jankú, Aung Naing, et al.. (2013). Target-Based Therapeutic Matching in Early-Phase Clinical Trials in Patients with Advanced Colorectal Cancer and PIK3CA Mutations. Molecular Cancer Therapeutics. 12(12). 2857–2863. 38 indexed citations
20.
Ganesan, Prasanth, et al.. (2011). Preliminary experience with the use of bendamustine. Hematology/Oncology and Stem Cell Therapy. 4(4). 157–160. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hikmat Abdel‐Razeq Breakdown of academic impact, for papers by Sang Kyun Sohn Breakdown of academic impact, for papers by Charles F. LeMaistre Breakdown of academic impact, for papers by Silvia Dehler Breakdown of academic impact, for papers by Ranjan Pathak Breakdown of academic impact, for papers by Arianna Simonetti Breakdown of academic impact, for papers by Matthew D. Seftel Breakdown of academic impact, for papers by Asim Belgaumi Breakdown of academic impact, for papers by Barry Meisenberg Breakdown of academic impact, for papers by Atul Sharma
Rankless by CCL
2026